DrugBiological
Vofatamab clinical trials
Also written MFGR1877S and B-701.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2010
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 1
Genentech, Inc. (2) · Fusion Pharmaceuticals Inc. (1) · Rainier Therapeutics (1) · Mark Pomerantz, MD (1)
Often tested with
Tested in the same studies.
Actinium Ac 225 Vofatamab (1) · Indium In 111 Vofatamab (1) · Pembrolizumab (1)
Studies
Open first, then newest update. How each study uses vofatamab is read from its arms, and is right about nine times in ten.
Testing it · 5
- A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid TumoursTerminatedPhase 1/2Fusion Pharmaceuticals Inc.NCT05363605Written as vofatamab
- Dose Escalation, Expansion Study of Vofatamab (B-701) in Treatment of Locally Advanced or Metastatic Urothelial Cell CarcinomaTerminatedPhase 1/2Rainier TherapeuticsNCT02401542Written as Vofatamab
- Ph 1B B-701 in Combination With Pembrolizumab in Metastatic Transitional Cell Carcinoma of the Urothelial TractTerminatedPhase 1Mark Pomerantz, MDNCT02925533Written as B-701
- Trial Evaluating the Safety and Pharmacokinetics of MFGR1877S in Patients With Advanced Solid TumorsCompletedPhase 1Genentech, Inc.NCT01363024Written as MFGR1877S
- A Study of the Safety and Pharmacokinetics of MFGR1877S in Patients With Relapsed or Refractory t(4;14)-Positive Multiple MyelomaCompletedPhase 1Genentech, Inc.NCT01122875Written as MFGR1877S
Given in every arm · 1 — vofatamab is usual care beside what is tested
Codes
What other systems call vofatamab · ClinicalTrials.gg INT006105
- MeSH (NLM) C573866vofatamabOne source NLM
- UNII (FDA) JMH6YR91PGVOFATAMABConfirmed FDA, NLM
- NCI Thesaurus C116863VofatamabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C573866 | vofatamab | One source NLM |
| UNII (FDA) | JMH6YR91PG | VOFATAMAB | Confirmed FDA, NLM |
| NCI Thesaurus | C116863 | Vofatamab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.